Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease.

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, affecting about 1/4th of the global population and causing a huge global economic burden. To date, no drugs have been approved for the treatment of NAFLD, making the correction of unhealthy lifestyles the principle method of treatment. Identifying patients with poor adherence to lifestyle correction and attempting to improve their adherence are therefore very important. AIM: To develop and validate a scale that can rapidly assess the adherence of patients with NAFLD to lifestyle interventions. METHODS: The Exercise and Diet Adherence Scale (EDAS) was designed based on compilation using the Delphi method, and its reliability was subsequently evaluated. Demographic and laboratory indicators were measured, and patients completed the EDAS questionnaire at baseline and after 6 months. The efficacy of the EDAS was evaluated in the initial cohort. Subsequently, the efficacy of the EDAS was internally verified in a validation cohort. RESULTS: The EDAS consisted of 33 items in six dimensions, with a total of 165 points. Total EDAS score correlated significantly with daily number of exercise and daily reduction in calorie intake (P < 0.05 each), but not with overall weight loss. A total score of 116 was excellent in predicting adherence to daily reduction in calorie intake (> 500 kacl/d), (sensitivity/specificity was 100.0%/75.8%), while patients score below 97 could nearly rule out the possibility of daily exercise (sensitivity/specificity was 89.5%/44.4%). Total EDAS scores ≥ 116, 97-115, and < 97 points were indicative of good, average, and poor adherence, respectively, to diet and exercise recommendations. CONCLUSION: The EDAS can reliably assess the adherence of patients with NAFLD to lifestyle interventions and have clinical application in this population.

Cold tolerance identification of nine Rosa L. materials and expression patterns of genes related to cold tolerance in Rosa hybrida.

Members of the Rosa genus have a high ornamental value, but their cultivation area is limited by their sensitivity to cold temperatures. The aim of this study was to evaluate the cold tolerance of a range of Rosa materials, and then determine which genes were related to cold tolerance. Nine Rosa materials were subjected to a cold treatment. To identify genes related to cold tolerance, R. hybrida was treated at -15°C for 10 min, and leaves collected before and after this treatment were collected for RNA-Seq analyses. The transcript profiles of four DEGs (POD17, NDUFA9, PMA1, and b-Amy1) in R. hybrida were determined by qRT-PCR at 0 h, 1 h, 2 h, and 3 h at -15°C. Nine Rosa materials were subjected to a cold treatment, and the most cold-tolerant materials were identified as those that showed the lowest levels of electrolyte leakage and the best recovery after 30 d of growth. The most cold-tolerant materials were Rosa hybrida, Rosa rugosa 'Pingyin 12', and Rosa rugosa. In total, 204 significantly differentially expressed genes (DEGs) were identified, of which 88 were significantly up-regulated and 116 were significantly down-regulated under cold conditions. Gene Ontology classification and Kyoto Encyclopedia of Genes and Genomes pathway analyses showed that the DEGs were enriched in 57 pathways, especially starch and sucrose metabolism, phenylpropane biosynthesis, MAPK signaling, fructose and mannose metabolism, and oxidative phosphorylation. By transcriptional analysis, PMA1, which was related to H+ ATPase activity, was continuously up-regulated, but the transcript levels of POD17, NDUFA9, and ß-Amy1 fluctuated during the freezing treatment. This research uncovered scarce cold-resistant materials and layed the foundation for further research on the cold tolerance mechanism of Rosa plants and the breeding of cold-tolerant varieties.

Porous biochar derived from walnut shell as an efficient adsorbent for tetracycline removal.

In this study, a high-performance porous adsorbent was prepared from biochar through a simple one-step alkali-activated pyrolysis treatment of walnut shells, and it was effective in removing tetracycline (TC). The specific surface area (SSA) of potassium hydroxide-pretreated walnut shell-derived biochar pyrolyzed at 900 °C (KWS900) increased remarkably compared to that of the pristine walnut shell and reached 1713.87 ± 37.05 m2·g-1. The maximum adsorption capacity of KWS900 toward TC was 607.00 ± 31.87 mg·g-1. The pseudo-second-order kinetic and Langmuir isotherm models were well suited to describe the TC adsorption process onto KWS900. The KWS900 exhibited high stability and reusability for TC adsorption in the presence of co-existing anions or cations over a wide pH range of 1.0-11.0. Further investigations demonstrated that the proposed adsorption mechanism involved pore filling, hydrogen bonding, π-π stacking, and electrostatic interaction. These findings provide a valuable reference for developing biochar-based adsorbents for pollutant removal.

An anode fabricated by Co electrodeposition on ZIF-8/CNTs/CF for peroxymonosulfate (PMS) activation.

A Co@ZIF-8/CNTs-CF anode for PMS activation was prepared by Co electrodeposition on carbon felt (CF) modified with ZIF-8 and carbon nanotubes (CNTs). The results showed that the fabricated Co@ZIF-8/CNTs-CF anode was an effective peroxymonosulfate (PMS) activator toward tetracycline (TC) removal. Compared with that in reaction system of bare CF anode + PMS, the reaction system of Co@ZIF-8/CNTs-CF anode + PMS exhibited 3.08 times decrease in the activation energy demanded and 4.21 times increase in the reaction rate constant (k), resulting in a kinetic favorable process of PMS activation by the Co@ZIF-8/CNTs-CF anode. The enhanced activation performance of the fabricated anode was ascribed to the high contents of the pyrrolic N and low valence state of Co in the Co@ZIF-8/CNTs-CF anode. Furthermore, the influence factors on the characteristics of transformation among the generated reactive species during the anodic PMS activation process were comprehensively investigated by the quenching experiments and the electron paramagnetic resonance (EPR) tests. The results showed that the SO4•- and reactive oxygen-containing reactive species (O2•- and 1O2) were generated during the activation of PMS by anode and became the major contributors toward TC removal. The production of 1O2 was through the dismutation of O2•-. In addition, the EPR experiments demonstrated that O2•- was generated mainly through the anodic PMS activation but the electrochemically driven molecular oxygen reduction reaction (ORR) process. The fabricated Co@ZIF-8/CNTs-CF anode for PMS activation provided a reference for the wastewater treatment based on the electrochemical advanced oxidation processes (EAOPs).

Combined Metabolome and Transcriptome Analyses Reveal the Flavonoids Changes and Biosynthesis Mechanisms in Different Organs of Hibiseu manihot L.

Hibiseu manihot L. (Jinhuakui, JHK), also known as a garden landscape plant, is widely cultivated as a landscape plant having pharmacological effects due to its high flavonoids content. Although flavonoids were the main active pharmaceutical ingredients in JHK, little information was obtained about the content, composition, and accumulation pattern of flavonoids in different tissues. Most studies only identified a few kinds of flavonoids in JHK limited by separation and identification problems. Therefore, combined metabolome and transcriptome analysis was performed to explore the accumulation patterns and biosynthesis mechanisms of flavonoids in JHK. In this study, we identified 160 flavonoids in 15 samples of JHK (flower, leaf, root, stem, and seeds) by using LC-MS/MS. Consistent with the total flavonoid content determination, these flavonoids were significantly accumulated in flowers, followed by leaves, stems, roots, and seeds. Among them, certain flavonoids, with high content, were also identified for the first time in JHK, such as tricetin, catechin, hesperidin, ncyanidin-3-O-sambubioside, astragalin, procyanidin B2/B3/C1, apigenin-5-O-glucoside, etc. Different tissues underwent significantly reprogramming of their transcriptomes and metabolites changes in JHK, particularly in the flavonoid, flavone, and flavonol biosynthesis pathways. We conducted a correlation analysis between RNA-seq and LC-MS/MS to identify the key genes and related flavonoids compounds, rebuild the gene-metabolites regulatory subnetworks, and then identified 15 key genes highly related to flavonoids accumulation in JHK. These key genes might play a fine regulatory role in flavonoids biosynthesis by affecting the gene expression level in different organs of JHK. Our results could be helpful for the improvement of the market/industrial utilization value of different parts of JHK, to pave the way for the regulatory mechanism research of flavonoids biosynthesis, and provide insight for studying the production quality improvement of JHK.

Silibinin augments the effect of clopidogrel on atherosclerosis in diabetic ApoE deficiency mice.

BACKGROUND: Diabetes mellitus (DM) abolishes the antithrombotic effect of Clopidogrel. Here, we investigated the synergistic effect of Silibinin on Clopidogrel-mediated atherosclerosis treatment in diabetic mice. METHODS: ApoE-/- mice were fed with high-fat diet (HFD) to establish the atherosclerotic model with diabetes. Animals were treated with Clopidogrel, Silibinin, or the combined to evaluate the protective effects on atherosclerosis and diabetes through Oil-red-O staining, qRT-PCR, Western blot, and metabolic measurements. Platelet activation and aggregation ex vivo assays were performed to detect the anti-thrombotic effect of different administrations. RESULTS: Silibinin significantly enhanced the inhibitory effect of Clopidogrel on atherosclerosis in DM mice. Co-administration of Silibinin with Clopidogrel remarkedly reduced the aortic lesion, inflammation, and endothelial dysfunction in aorta roots, and diabetic symptoms were significantly improved by the Silibinin-Clopidogrel treatment in HFD-fed ApoE-/- mice. Interestingly, the anti-thrombotic effect of Clopidogrel was further augmented by the Silibinin treatment in atherosclerotic mice. CONCLUSION: In atherosclerotic mouse model, Silibinin significantly improves the effect of Clopidogrel on atherosclerosis.

Norm index-based QSPR model for describing the n-octanol/water partition coefficients of organics.

The n-octanol/water partition coefficient (logKow) is widely used in the environmental, agricultural and pharmaceutical fields for the risk evaluation and application of organic chemicals. In this work, grounded on atomic distribution matrices, a norm index-based QSPR model was built for organic chemicals with 18 kinds of diverse structures. The statistical results (R2 = 0.9037, RMSE = 0.4515) showed that the QSPR model for describing the logKow of organics was fitted well. Various validation results showed that the model had good robustness, good predictability and wide applicability. These satisfactory results indicated that the model was applicable for the logKow description of organic chemicals and that norm descriptors were reliable and general for the description of organic structures. The model was relatively better at describing logKow for aromatics, alcohols, nitriles, esters, amides, halogenated compounds, acids and amine compounds. The intensity of spatial branching and the space charge distribution intensity descriptors could have a greater impact on the logKow value of a compound.

[Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].

OBJECTIVE: To investigate the value of controlled attenuation parameter (CAP) in the diagnosis of fatty liver using FibroScan in patients with chronic liver disease (CLD). METHODS: A prospective cohort study was performed for the patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), and non-alcoholic fatty liver disease (NAFLD) who underwent liver pathological examination followed by CAP measurement within 1 week in The Second People's Hospital of Tianjin from February 2013 to May 2014. According to related guidelines, hepatocyte steatosis was classified as S0: <5%, S1: 5%-33%, S2: 34%-66%, or S3: ≥67%. The receiver operating characteristic (ROC) curves were plotted with positive results as the diagnostic criteria, and the optimal cut-off values were determined at the maximum Youden index. Single linear regression and multiple stepwise regression were applied to analyze the influencing factors for CAP. RESULTS: A total of 427 patients were enrolled, consisting of 19 patients (4.4%) with NAFLD, 383 (89.7%) with CHB, and 25 (5.9%) with CHC. The optimal cut-off values for CAP in the diagnosis of steatosis ≥5%, ≥34%, and ≥67% were 230 dB/m, 252 dB/m, and 283 dB/m, respectively, and the areas under the ROC curve were 0.803, 0.942, and 0.938, respectively (Z = 14.194, 28.385, and 16.486, respectively, all P < 0.01). CAP differentiated S0 from S1, S1 from S2, S0 from S2, S0 from S3, and S1 from S3 (Z = 10.109, 10.224, 47.81, 29.917, and 10.999, all P < 0.01), but was not able to differentiate S2 from S3 (Z = 0.656, P = 0.5116). The single linear regression and multiple stepwise regression analyses showed that only body mass index (BMI; B = 4.001, P < 0.01) and hepatic steatosis (B = 33.015, P = 0.000) were correlated with CAP. The coincidence rates between CAP and liver pathological diagnosis were 77.4%, 81.0%, and 96.2% for S0, S3, and ≥S2, respectively. CONCLUSION: CAP has a good value in the diagnosis of fatty liver in CLD patients, and can well differentiate between all stages of fatty liver except S2 and S3. CAP is influenced by BMI, but is not found to be associated with liver fibrosis, inflammation, liver stiffness measurement, and etiology.

[Impact of liver steatosis on the curative effect of pegylated interferon-alpha-2a in patients with chronic hepatitis B].

OBJECTIVE: To investigate the impact of hepatic steatosis on virologic response to treatment with pegylated interferon-alpha-2a (PEG-IFNα-2a) in chronic hepatitis B (CHB) patients. METHODS: We retrospectively analyzed 50 biopsy-proven cases of CHB in patients who had been administered a 48-week course of PEG-IFNα-2a in our hospital between 2005 and 2009. The patients were stratified according to presence of steatosis confirmed by pathological findings, with 28 in the non-steatosis group and 22 in the steatosis grouP(21 with mild steatosis,and 1 with moderate steatosis). RESULTS: from blood routine test,hepatic and renal function tests, fasting blood glucose test, thyroid function test and blood lipid test were collected for analysis, as were results from hepatitis B viral load test and detection of hepatitis B virus (HBV) markers and autoantibodies. The efficacy of antiviral treatment and side effects were compared between the stratified groups by statistically comparing the results from before and after the 48 weeks of treatment. RESULTS: At the end of treatment, the non-steatosis group had 42.9% of patients with undetectable HBV-DNA ( less than 500 copies/ml), a hepatitis B e antigen (HBeAg) seroconversion rate of 31.6% and a complete response rate of 39.3%. The steatosis group had a lower rate of patients with undetectable HBV-DNA (40.9%) and higher rates of HBeAg seroconversion (33.3%) and complete response (40.9%), but none of the differences reached the threshold for statistical significance (x2=0.012, 0.019, 0.014 and P=0.560,0.600,0.568 respectively). Both groups showed significant increases in triglyceride levels after treatment (steatosis group:t =-2.164, P=0.040; non-steatosis group:t =-2.863, P=0.009), and there was a significant difference between the two groups (t=2.41, P=0.020). CONCLUSION: Our study did not show that mild hepatic steatosis affected the efficiency of a 48-week course of PEG-IFNα-2a treatment for patients with CHB.

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

BACKGROUND AND AIM: The controlled attenuation parameter (CAP) using transient elastography (TE) was validated in chronic hepatitis C to evaluate hepatic steatosis; however, limited data are available on chronic hepatitis B (CHB). Therefore, we assessed the accuracy and the efficacy of CAP for the detection of steatosis in CHB. METHODS: Consecutive CHB patients underwent liver biopsy and liver stiffness measurements (LSM) with simultaneous CAP determination using the M probe of the TE. The area under the receiver operating characteristics curve (AUROC) was used to evaluate the performance of CAP in diagnosing steatosis compared with biopsy. RESULTS: A total of 340 patients were included: 60 % were male, the median age was 37 years; the body mass index (BMI) was ≥ 28 kg/m(2) for 14 % of the subjects; and the distribution of the steatosis grade was S0 58.2 %, S1 34.2 %, S2 5.0 % and S3 2.6 %. The median (range) of CAP was 218 (100-400) dB/m, and CAP correlated with the BMI (ρ = 3.622) and steatosis grade (ρ = 29.203) according to a multivariate analysis (both P < 0.001). CAP could detect the different grades of steatosis: ≥ S1 with AUROC of 0.81 at a cutoff of 224 dB/m, ≥ S2 with AUROC of 0.90 at a cutoff of 236 dB/m and ≥ S3 with AUROC of 0.97 at a cutoff of 285 dB/m. Furthermore, the LSM and fibrosis and activity grades on biopsy did not influence the CAP performance. CONCLUSIONS: CAP presented excellent diagnostic performance for severe steatosis with high sensitivity and specificity in Chinese patients with CHB.